Clay Bullard travels around the country educating healthcare professional on Medication Management, via pharmacogenomic testing.
Clay Bullard, President
PGx Medical
PGx Medical President, Clay Bullard has made it his goal to reach as many healthcare providers as possible to educate them on a tool that is available to manage medications. Clay’s passion for the test shows when he asks providers, “if this was your loved one, would you want to know if their medication is working properly? You don’t know, what you don’t know. And our simple buccal swab of the cheek will tell you if your loved one is even capable of metabolizing their medications.
“Pharmacogenomics isn’t new, it has been around for a long time,” said Bullard. What is bringing it to the forefront of the healthcare industry is how affordable it has become. PGx Medical works with hundreds of senior communities, clinics and pharmacies across the country and there is no cost for patients with Medicare B. And in select states, Medicaid reimburses for the test as well.
Adverse reactions attributable to prescription drug use cause an estimated 100,000 deaths and more than two million serious reactions in the United States each year, costing the healthcare industry more than $136 billion annually. By 2030, about 72 million people will be 65 or older. Today’s seniors live longer than before, which makes it important to make your extra years as fun-filled and pain-free as possible.
“Our PGx Medical team works with physicians and care providers who are desiring to increase medical efficiencies, reduce cost, increase better outcomes and ultimately do the best they can for each individual patient,” said Bullard.
For more information on pharmacogenomic testing, or to schedule PGx Medical to educate your group or organization, contact:
PGx Medical
info@pgxmed.com
405-509-5112